Beyond Retrograde Menstruation: New Research Links Endometriosis to Immune Dysfunction and Stem Cells

Endometriosis occurs when tissue resembling the uterine lining grows outside the uterus. It is commonly linked with chronic pelvic pain, painful periods, pain during intercourse, abnormal bleeding, and infertility. Although it affects many women of reproductive age, diagnosis is often delayed because symptoms can overlap with other gynecologic, gastrointestinal, or urinary conditions. For decades, one of the leading explanations for endometriosis has been retrograde menstruation, in which menstrual tissue flows backward through the fallopian tubes into the pelvic cavity. However, because retrograde menstruation can occur in many people who never develop endometriosis, researchers have looked for additional factors that explain why lesions persist in some patients.

The review highlights immune dysregulation as a central feature. In a healthy pelvic environment, immune cells would be expected to clear displaced endometrial cells. In endometriosis, however, macrophages, T cells, B cells, natural killer cells, cytokines, and inflammatory mediators appear to behave abnormally, creating conditions that allow ectopic tissue to escape immune surveillance. The article also discusses the possibility that primitive endometrial or Müllerian-derived stem cells may become misplaced during early development of the female reproductive tract. These cells could remain dormant until hormonal or inflammatory signals after puberty activate them, enabling them to develop into glandular, stromal, and epithelial components of endometriotic tissue.

Genes involved in reproductive tract development, including Hoxa and Wnt gene families, are described as possible contributors to this process. Disruption in these developmental pathways could affect cell migration, tissue patterning, and stem-cell behavior, potentially setting the stage for ectopic lesions later in life.

Once lesions are established, the surrounding peritoneal microenvironment may shift toward chronic inflammation, angiogenesis, and tissue remodeling. Macrophages may become polarized toward phenotypes that support repair and vessel formation rather than clearance. Natural killer cell activity may be reduced, while T-cell and cytokine patterns may change as disease severity increases.

Several inflammatory molecules are described as important in this process, including interleukins, tumor necrosis factor alpha, transforming growth factor beta, prostaglandins, vascular endothelial growth factor, adhesion molecules, and matrix metalloproteinases. Together, these mediators may help lesions attach, invade surrounding tissue, develop a blood supply, and resist programmed cell death.

The findings support a broader view of endometriosis as a disease shaped by hormonal signaling, immune dysfunction, genetic susceptibility, developmental biology, and stem-cell behavior. This may help explain why symptoms vary widely, why lesions can recur after treatment, and why some patients experience disease outside the pelvis.

Researchers suggest that future diagnostic and therapeutic strategies may need to move beyond lesion removal and hormone suppression alone. Better understanding of immune-cell behavior, inflammatory signaling, stem-cell niches, and developmental pathways could eventually support more targeted approaches for pain control, fertility preservation, and recurrence prevention.

The article presents endometriosis as a multifactorial disease in which misplaced developmental cells and immune dysregulation may work together. In this model, ectopic cells survive because the immune system fails to eliminate them and, over time, the inflammatory environment helps those cells form persistent lesions.

Source: Hindawi Publishing Corporation Obstetrics and Gynecology International. Volume2013,ArticleID527041. http://dx.doi.org/10.1155/2013/527041